Search Tag: #ESCCongress2023
2023 27 Aug
A recent trial involving all hospitals in London, U.K., reports no disparity in survival at 30 days in patients with resuscitated cardiac arrest who were transported by ambulance to a cardiac arrest centre or the nearest emergency department. These findings were presented during a Hot Line session at the ESC Congress 2023. Sudden cardiac arrest...Read more
2023 27 Aug
Late-breaking research presented in a Hot Line session at the ESC Congress 2023 reveals that Optical Coherence Tomography (OCT)-guided percutaneous coronary intervention (PCI), results in a larger minimum stent area. However, it does not reduce the two-year rate of target vessel failure when compared with angiography-guided PCI. The use of OCT-guided...Read more
2023 26 Aug
New research presented at the ESC Congress 2023 reveals that cardiovascular disease (CVD) costs the European Union (EU) an estimated €282 billion in 2021. The analysis was a collaborative study by the European Society of Cardiology (ESC) and the University of Oxford, UK. This figure highlights the significant impact of CVD on the region. ...Read more
2023 26 Aug
Late-breaking research presented at ESC Congress 2023 reveals that qiliqiangxin, a traditional Chinese medicine, effectively reduces hospitalisations due to heart failure and cardiovascular-related deaths among patients suffering from heart failure and reduced ejection fraction (HFrEF). Derived from a blend of 11 distinct herbs, qiliqiangxin...Read more
2023 25 Aug
In recent breakthrough research presented during a Hot Line session at ESC Congress 2023, semaglutide's effectiveness in improving symptoms and physical function related to heart failure and inducing greater weight loss was reported. Nearly 50% of heart failure patients are affected by heart failure with preserved ejection fraction (HFpEF)....Read more
2023 16 Aug
The biggest cardiovascular scientific event of the year - ESC Congress 2023, begins soon! Onsite in Amsterdam and online: 25 to 28 August 2023 There will be nine Hot Line Press Conferences, offering an initial glimpse into the findings of 30 significant studies in cardiovascular disease, along with the opportunity to engage with the researchers...Read more